Company
Lindy Bio
Lindy is Developing Patient-centric Biotherapeutic Drug Delivery Technology
Also known as Lindy Biosciences, LINDY BIOSCIENCES, INC.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Customers
- industry partners who are developing biotherapeutic drug products
- Legal name
- LINDY BIOSCIENCES, INC.
- lindybio.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Lindy Biosciences has developed a dehydration technology that enables suspensions of highly concentrated proteins, allowing higher dosing in smaller volumes, ultimately reducing the time patients spend taking medication.
Funding snapshot
- Total raised
- $5.7MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Undisclosed, $4.2M2022-07
Funding rounds
- Round, 2024
- $1.7M2024-03-12, SEC form D sold, 10 investors
- Round, 2022
- $4.2M2022-07, Company stated
- Round, 2022
- $3.3M2022-03-11, SEC form D sold, 29 investors
- Round, 2019
- $548K2019-01-11, SEC form D sold, 6 investors
- Round, 2018
- $150K2018-03-06, SEC form D sold, 1 investor
Loading relationship preview